Luteolin also inhibited cancer cell development via the Wnt β-catenin pathway, and may clearly halt the cell cycle by decreasing Akt-phosphorylation, which further leads to dephosphorylation and triggers GSK-3 (glycogen synthase kinase). The gene discussed is AKT1; the disease is cancer.